DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets has announced the addition of GlobalData's report "Belgium Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery" to their offering.
The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Scope
- Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Belgium Diabetes Care Devicesmarket.
- Key players covered include Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Sanofi, Medtronic, Inc., LifeScan, Inc. and others.
Reasons to Buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Belgium Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Companies Mentioned
- ARKRAY
- Abbott Laboratories
- Animas Corporation
- Bayer HealthCare
- Becton, Dickinson and Company
- Eli Lilly and Company
- F. Hoffmann-La Roche
- LifeScan
- Medtronic
- Nipro Corporation
- Novo Nordisk
- Sanofi
- Ypsomed Holding
For more information visit http://www.researchandmarkets.com/research/bsfx9v/belgium_diabetes
Source: GlobalData